Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

New insights into SARS-CoV-2 viral diversity

The first comprehensive, large-scale analysis available on the preprint server bioRxiv attempted to identify specific genomic signatures of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains within and across individual hosts – revealing recombination events, specific geographic profiles, as well as multi-strain and/or superinfections characteristic for the coronavirus disease (COVID-19) pandemic.

14 May 2020

Continuously active antiviral coating may reduce the spread of COVID-19

Surfaces coated with a quaternary ammonium polymer have remarkable antiviral properties. They may even be capable of reducing the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in areas with high risk for contamination, such as indoor environments or public places. University of Arizona researchers explain the antiviral potential of these in a new study published on the preprint server medRxiv.

14 May 2020

NIH begins clinical study to evaluate hydroxychloroquine and azithromycin for COVID-19

A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19).

14 May 2020

New clinical trial to investigate the efficacy of ivermectin against COVID-19

Clínica Universidad de Navarra and the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Foundation, have launched a clinical trial to investigate the efficacy of ivermectin against COVID-19.

14 May 2020

MU Health Care neurologist publishes recommendations for stroke treatment in COVID-19 patients

A University of Missouri Health Care neurologist has published more than 40 new recommendations for evaluating and treating stroke patients based on international research examining the link between stroke and novel coronavirus (COVID-19).

14 May 2020

Study finds increase in home wine consumption during confinement

Among other conclusions, the study also adds that 33% of people polled declare they spend more on wine during confinement. Furthermore, solitary consumption has increased and the phenomenon of digital snacking has emerged.

14 May 2020

Rice engineer receives NSF grant to study effect of varying temperatures on coronavirus

Daniel Preston, an assistant professor of mechanical engineering at Rice's Brown School of Engineering, has received a National Science Foundation Rapid Response Research grant to study the effect of varying temperatures on the lifetime of the virus responsible for the COVID-19 pandemic.

14 May 2020

ACTG initiates clinical trial to evaluate treatment for COVID-19

The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2).

14 May 2020

KHN’s ‘What the Health?’: What’s in the next round of COVID-19 relief?

House Democrats are moving ahead with another round of COVID-19 relief, including additional funding for state Medicaid programs, an open enrollment period for the Affordable Care Act's marketplace plans, and money to pay premiums for newly unemployed Americans to continue on their employer health coverage.

14 May 2020

Anti-inflammatory drug may improve respiratory function in some severe COVID-19 cases

A small study in Greece found that the clinically approved anti-inflammatory drug anakinra, used to treat rheumatoid arthritis, improved respiratory function in patients with severe coronavirus disease 2019 (COVID-19).

14 May 2020

11 healthcare centers participate in clinical trial of Russian drug against novel coronavirus

Initially, the drug was developed to treat rheumatoid arthritis. BIOCAD developers receive regulatory authorization as part of the procedure approved by Decree No. 441 of the Government of the Russian Federation of April 4, 2020 since the mechanism of action of the active substance is associated with the cytokine storm, a life-threatening immune system response in patients with COVID-19.

14 May 2020

In reversal, Kansas will count all positive COVID cases, even asymptomatic ones

Kansas leaders will include asymptomatic COVID-19 cases in their assessments of virus trends as they evaluate when to take further steps to ease stay-at-home orders and other social distancing measures.

14 May 2020

Trump’s comparison of COVID-19 death rates in Germany, US is wrong

Following weeks of criticism over his administration's COVID-19 response, President Donald Trump pulled out new statistics to claim the nation is actually among the best in the world in fighting the lethal coronavirus.

14 May 2020

Low-cost PCR test designed to detect coronavirus

The project of Consuelo Rubio has been among those chosen for the call of the Valencian System of Innovation and Research for the COVID-19 emergency.

14 May 2020

Masks made from simple fabric offer limited protection, say experts

Ensuring the protection of people's health and lives, especially in respirators and personal protective equipment (PPE) for use by health care personnel, has been one of the essential premises since the Artefactos community began to design and manufacture adaptations with which to face Covid-19.

14 May 2020